Inducing an order-order morphological transition via chemical degradation of amphiphilic diblock copolymer nano-objects by Ratcliffe, L. et al.
Inducing an Order−Order Morphological Transition via Chemical
Degradation of Amphiphilic Diblock Copolymer Nano-Objects
Liam P. D. Ratcliﬀe,*,† Claudie Couchon,† Steven P. Armes,*,† and Jos M. J. Paulusse*,‡
†Dainton Building, Department of Chemistry, The University of Sheﬃeld, Brook Hill, Sheﬃeld, South Yorkshire S3 7HF, United
Kingdom
‡Department of Biomaterials Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, Faculty of
Science and Technology University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands
*S Supporting Information
ABSTRACT: The disulﬁde-based cyclic monomer, 3-methyl-
idene-1,9-dioxa-5,12,13-trithiacyclopentadecane-2,8-dione
(MTC), is statistically copolymerized with 2-hydroxypropyl
methacrylate to form a range of diblock copolymer nano-
objects via reversible addition−fragmentation chain transfer
(RAFT) polymerization. Poly(glycerol monomethacrylate)
(PGMA) is employed as the hydrophilic stabilizer block in
this aqueous polymerization-induced self-assembly (PISA) formulation, which aﬀords pure spheres, worms or vesicles depending
on the target degree of polymerization for the core-forming block. When relatively low levels (<1 mol %) of MTC are
incorporated, high monomer conversions (>99%) are achieved and high blocking eﬃciencies are observed, as judged by 1H
NMR spectroscopy and gel permeation chromatography (GPC), respectively. However, the side reactions that are known to
occur when cyclic allylic sulﬁdes such as MTC are statistically copolymerized with methacrylic comonomers lead to relatively
broad molecular weight distributions. Nevertheless, the worm-like nanoparticles obtained via PISA can be successfully
transformed into spherical nanoparticles by addition of excess tris(2-carboxyethyl)phosphine (TCEP) at pH 8−9. Surprisingly,
DLS and TEM studies indicate that the time scale needed for this order−order transition is signiﬁcantly longer than that required
for cleavage of the disulﬁde bonds located in the worm cores indicated by GPC analysis. This reductive degradation pathway may
enable the use of these chemically degradable nanoparticles in biomedical applications, such as drug delivery systems and
responsive biomaterials.
■ INTRODUCTION
Degradable polymers have been the subject of signiﬁcant and
sustained research, not least for their potential in the design of
therapeutic devices such as temporary prostheses, scaﬀolds for
tissue engineering and controlled drug delivery vehicles.1−4
This has resulted in the development of a diverse range of
materials based on either naturally occurring or entirely
synthetic feedstocks.5 The extent and rate of degradability of
these materials is primarily determined by the type and number
of cleavable chemical bonds that are incorporated within the
polymer chains, as well as their precise location.6 Anhydride,
ester, amide, and disulﬁde bonds have been successfully
employed, enabling chemical degradation via exposure to either
photo, thermal, mechanical, or chemical stimuli.1,2,5−9 To
ensure that suﬃciently high levels of degradability can be
achieved, such labile bonds are incorporated into the polymer
backbone using techniques such as step polymerization10−17 or
ring-opening polymerization (ROP).15−23 Although signiﬁcant
progress has been made, conferring chemical degradability on
vinyl polymers undoubtedly remains a signiﬁcant technical
challenge.24
The development of reversible deactivation radical polymer-
ization (RDRP) techniques such as nitroxide-mediated
polymerization (NMP),25 atom transfer radical polymerization
(ATRP),26,27 and reversible addition−fragmentation chain
transfer (RAFT) polymerization28 has led to the design of
many new controlled-structure copolymers based on vinyl
monomers.29,30 Moreover, formulations based on polymer-
ization-induced self-assembly (PISA)31−33 enable the eﬃcient
synthesis of a wide range of nano-objects at high solids (up to
50% w/w)34 in either polar or non-polar solvents.34−37 A
prototypical PISA formulation involves the RAFT aqueous
dispersion polymerization of 2-hydroxypropyl methacrylate
(HPMA) using a poly(glycerol monomethacrylate) (PGMA)
macromolecular chain transfer agent (macro-CTA).38,39 Under
certain conditions, PGMA−PHPMA diblock copolymer chains
self-assemble in situ to produce worm-like micelles.37 These
highly anisotropic nanoparticles form soft, free-standing
aqueous gels at 20 °C. Moreover, a morphological trans-
formation from worms to spheres can be induced on cooling to
5 °C.40,41 This order−order transition is fully reversible and
enables convenient sterilization of such worm gels via cold
ultraﬁltration.38 Such worm gels are currently being evaluated
for in vitro applications such as a long-term storage medium for
Received: April 14, 2016
Revised: May 25, 2016
Article
pubs.acs.org/Biomac
© XXXX American Chemical Society A DOI: 10.1021/acs.biomac.6b00540
Biomacromolecules XXXX, XXX, XXX−XXX
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,
provided the author and source are cited.
human stem cells42 and also for the cryopreservation of red
blood cells.43 Nevertheless, the nondegradability of the
methacrylic backbone is a major barrier for potential in vivo
biomedical applications.
Several methodologies have been explored to circumvent this
important problem. For example, branched degradable vinyl
copolymers have been designed using disulﬁde,44,45 acetal,46 or
silyl ether47 comonomers. Alternatively, a central degradable
unit can be introduced via ATRP by using a disulﬁde-based
bifunctional initiator.48,49 Such approaches have been recently
reviewed by Rikkou and Patrickios, who have focused on
copolymers prepared via either living or pseudoliving
techniques.50 Another strategy involves coupling telechelic
polymers (typically via postpolymerization oxidation of thiols)
to produce degradable materials.51−55 Alternatively, ring-
opening polymerization (ROP) of a cyclic monomer
(containing a cleavable functionality such as an ester) has
been combined with vinyl polymerization. For example, Frick
and co-workers56 coupled the ROP of lactide with the anionic
polymerization of isoprene to produce various ABA triblock
copolymers. Several groups have prepared bespoke RAFT
CTAs that enable both ROP of lactide and controlled vinyl
polymerization.57−59 Similar dual-functional nitroxides and
ATRP initiators have also been utilized in this context.60
Mecerreyes et al. designed an acrylic monomer containing
caprolactone functionality, making it suitable for both ROP and
ATRP.61 This was subsequently polymerized to form cleavable
branched structures. Li and Armes prepared highly branched
methacrylic copolymers using a disulﬁde dimethacrylate
comonomer that enabled the primary chains within the
branched structure to be characterized via postpolymerization
cleavage.62 A similar approach was used by Armes and co-
workers to design chemically degradable poly(2-hydroxyethyl
methacrylate)-based ﬁbers.63
More recently, there has been growing interest in the radical
ring-opening polymerization (RROP)64 of cyclic ketene
acetals65−68 and cyclic allylic sulﬁdes.69−71 Such monomers
can be copolymerized with vinyl monomers to aﬀord
chemically degradable vinyl copolymers.72,73 There are a
number of literature reports utilizing RDRP techniques to
(co)polymerize cyclic ketene acetals, including RAFT,74,75
NMP,76,77 and ATRP.78,79 However, as far as we are aware,
there is currently only a single literature example describing the
RDRP of cyclic allylic sulﬁdes.80
In the present study, a small amount of a cyclic allylic sulﬁde,
3-methylidene-1,9-dioxa-5,12,13-trithiacyclopentadecane-2,8-
dione (MTC),80 is statistically copolymerized with 2-hydrox-
ypropyl methacrylate using an aqueous PISA formula-
tion.31,38,40 The MTC comonomer introduces a disulﬁde
bond into the methacrylic backbone of the hydrophobic
component of an amphiphilic diblock copolymer, which has
been recently shown to exhibit excellent biocompatibility for
various cell types, including human stem cells and red blood
cells.40,42,43 Subsequent reductive cleavage under appropriate
conditions81 leads to a signiﬁcantly shorter hydrophobic block,
which is suﬃcient to produce a change in the morphology of
the diblock copolymer nano-objects produced during PISA. In
principle, such an order−order transition may be suﬃcient to
allow a renal clearance mechanism, which suggests the
possibility of in vivo biomedical applications.
■ EXPERIMENTAL SECTION
Materials. 2-Hydroxypropyl methacrylate (HPMA, 97%) and 4,4′-
azobis(4-cyanopentanoic acid) (ACVA; V-501; 99%) were purchased
from Alfa Aesar (Heysham, U.K.) and used as received. Glycerol
monomethacrylate (GMA, 99.8%) was kindly donated by GEO
Specialty Chemicals (Hythe, U.K.) and used without further
puriﬁcation. 3-Methylidene-1,9-dioxa-5,12,13-trithiacyclopentadecane-
2,8-dione (MTC) was synthesized as described elsewhere.80 2-Cyano-
2-propyl benzodithioate (CPDB) was purchased from Strem
Chemicals (Cambridge, U.K.) and tris(2-carboxyethyl)phosphine
(TCEP hydrochloride, 99%) was purchased from Amresco (Solon,
Ohio, U.S.A.). Deuterated methanol (CD3OD) was purchased from
Goss Scientiﬁc (Nantwich, U.K.). Sodium hydroxide pellets were
purchased from VWR (Lutterworth, U.K.). Deionized water was used
for all dispersion polymerizations. All other solvents were of HPLC
quality, purchased from Fisher Scientiﬁc (Loughborough, U.K.) and
used as received.
Synthesis and Puriﬁcation of PGMA56 Macro-CTA. A typical
protocol for the synthesis of PGMA56 macro-CTA is as follows. To a
round-bottomed ﬂask containing CPDB RAFT agent (75% purity,
0.020 mol, 6.03 g), GMA monomer (1.268 mol, 203.0 g) and ethanol
(3.38 mol, 156.0 g) was added to target a mean degree of
polymerization (DP) of 63. To this, ACVA initiator (4.07 mmol,
1.14 g; CTA/ACVA molar ratio = 5.0) was added, and the resulting
pink solution was sparged with N2 for 20 min before the sealed ﬂask
was immersed into an oil bath set at 70 °C. After 140 min (69%
conversion as judged by 1H NMR), the GMA polymerization was
quenched by immersing the ﬂask in an ice bath and exposing the
reaction solution to air. The crude polymer solution was then
precipitated into a 10-fold excess of DCM (twice) and then washed
three times with DCM before being dissolved in water and lyophilized
overnight. 1H NMR analysis indicated a mean DP of 56 for this
PGMA macro-CTA. Taking into account the target DP of 63 and the
GMA conversion of 69%, this suggests a CTA eﬃciency of 76%. DMF
GPC analysis (refractive index detector; vs a series of poly(methyl
methacrylate) calibration standards) indicated Mn and Mw/Mn values
of 14300 g mol−1 and 1.14, respectively.
RAFT Synthesis of PGMA56-P(HPMA180-stat-MTC0.9) Diblock
Copolymer. A typical protocol for the synthesis of PGMA56-
P(HPMA180-stat-MTC0.9) statistical diblock copolymer is as follows:
MTC monomer (0.0036 g, 0.011 mmol) was added to a glass vial or
round bottomed ﬂask, followed by HPMA monomer (0.3388 g, 2.35
mmol), PGMA56 macro-CTA (0.12 g, 0.013 mmol), and water (4.17 g,
to produce 10% w/w total solids). ACVA was then added (0.9 mg,
0.003 mmol, macro-CTA/ACVA molar ratio = 4.0), and the solution
was sparged with N2 for 30 min. The ﬂask was sealed and immersed in
an oil bath set at 70 °C and stirred for 16 h to ensure complete
monomer conversion. The polymerization was quenched by exposure
to air and cooling the ﬂask to 20 °C.
Addition of Reducing Agent to PGMA56-P(HPMA180-stat-
MTC0.9) Diblock Copolymer. The protocol is as follows: To
PGMA56-P(HPMA180-stat-MTC0.9) statistical diblock copolymer (3.00
g of 10% w/w dispersion, 0.0076 mmol of MTC) TCEP reducing
agent (0.011 g, 0.038 mmol, TCEP/MTC molar ratio = 5) was added,
followed by 1 M NaOH solution to adjust the ﬁnal pH to between 8
and 9. The reaction solution was agitated on a roller at 20 °C and
sampled as required.
RAFT Synthesis of PGMA56-PHPMA180 Diblock Copolymer. A
typical protocol for the synthesis of PGMA56-PHPMA180 statistical
diblock copolymer is as follows: PGMA56 macro-CTA (0.1124 g, 0.012
mmol), HPMA monomer (0.3122 g, 2.15 mmol), and water (3.79 g,
to produce 10% w/w total solids) were added to a glass vial or round
bottomed ﬂask. ACVA was then added (0.8 mg, 0.003 mmol, macro-
CTA/ACVA molar ratio = 4.0), and the solution was sparged with N2
for 30 min. The ﬂask was sealed and immersed in an oil bath set at 70
°C and stirred for 16 h to ensure complete monomer conversion. The
polymerization was quenched by exposure to air and cooling the ﬂask
to 20 °C.
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Copolymer Characterization. 1H NMR Spectroscopy. All NMR
spectra were recorded using a 400 MHz Bruker Avance-400
spectrometer (64 scans per sample) in CD3OD or CDCl3.
Gel Permeation Chromatography (GPC). Polymer molecular
weights and polydispersities were determined using a DMF GPC
instrument operating at 60 °C that comprised two Polymer
Laboratories PL gel 5 μm Mixed C columns and one PL gel 5 μm
guard column connected in series to an Agilent Technologies 1260
Inﬁnity multidetector suite (refractive index detector only) and an
Agilent Technologies 1260 ISO pump ﬁtted with a 1260 ALS
autosampler. The GPC eluent was HPLC-grade DMF containing 10
mM LiBr and was ﬁltered prior to use. The ﬂow rate used was 1.0 mL
min−1 and DMSO was used as a ﬂow-rate marker. Calibration was
conducted using a series of 10 near-monodisperse poly(methyl
methacrylate) standards (Mn = 625−618000 g mol−1, K = 2.094 ×
10−3, α = 0.642). Chromatograms were analyzed using Agilent
Technologies GPC/SEC software version 1.2.
Transmission Electron Microscopy (TEM). Reaction mixtures were
diluted at 20 °C to generate 0.60% w/w dispersions. Copper TEM
grids (Agar Scientiﬁc, U.K.) were surface-coated in-house to yield a
thin ﬁlm of amorphous carbon. The grids were then plasma glow-
discharged for 40 s to create a hydrophilic surface. Each aqueous
diblock copolymer dispersion (11 μL) was placed onto a freshly glow-
discharged grid for 1 min and then blotted with ﬁlter paper to remove
excess solution. To stain the deposited nanoparticles, a 0.75% w/w
aqueous solution of uranyl formate (11 μL) was placed via
micropipette on the sample-loaded grid for 15 s and then carefully
blotted to remove excess stain. Each grid was then carefully dried using
a vacuum hose. Imaging was performed at 100 kV using a Phillips
CM100 instrument equipped with a Gatan 1 k CCD camera.
Dynamic Light Scattering (DLS). Intensity-average hydrodynamic
diameters of the dispersions were obtained by DLS using a Malvern
Zetasizer NanoZS instrument. Dilute aqueous dispersions (0.25% w/
w) were analyzed using disposable cuvettes, and all data were averaged
over three consecutive runs.
■ RESULTS AND DISCUSSION
Paulusse et al. have reported the statistical copolymerization of
MTC with methyl methacrylate, 2-hydroxyethyl methacrylate,
or 2-dimethylaminoethyl methacrylate using RAFT solution
polymerization in either chlorobenzene or dimethylforma-
mide.80 Higher levels of MTC in the comonomer feed led to a
gradual loss of control over the molecular weight distribution
and also produced lower comonomer conversions. Bearing this
prior study in mind, a small amount of MTC was statistically
copolymerized with HPMA to introduce chemically degradable
disulﬁde units into the methacrylic backbone of the
predominantly PHPMA core-forming block using a RAFT
aqueous dispersion polymerization formulation (see Figure 1).
First, a PGMA56 macro-CTA was prepared via RAFT
solution polymerization in ethanol, as previously described.82
Then the statistical copolymerization of MTC with HPMA was
conducted using this macro-CTA, with 2 mol % MTC being
utilized relative to the HPMA target DP of 180. The resulting
diblock copolymer had a relatively broad molecular weight
distribution (Mw/Mn = 1.52, as judged by DMF GPC, see
Figure S1) compared to similar PGMA56-PHPMAy copolymers
prepared in the absence of any MTC.39,83 Moreover, the overall
comonomer conversion was only 84% after 16 h at 70 °C, as
judged by 1H NMR spectroscopy. When the MTC content was
reduced to 1 mol %, the ﬁnal conversion exceeded 98%, but the
dispersity was only slightly reduced (Mw/Mn = 1.44). Such
relatively high Mw/Mn values may explain why only mixed
phases (e.g., spheres plus worms or vesicles plus worms) were
observed when these dispersions were analyzed using TEM
(see Figure S2). Fortunately, further lowering the MTC
content to 0.50 mol % led to slightly lower dispersities (Mw/
Mn < 1.40), and more than 99% comonomer conversion was
achieved in all cases. Moreover, relatively pure spherical, worm-
like, or vesicular morphologies could be obtained (see Figure
S3), although rather higher core-forming block DPs were
required to produce worm and vesicle phases compared to that
needed for similar PGMA−PHPMA diblock copolymers
prepared in the absence of MTC (see Figure S4). Interestingly,
the DP range over which the worm phase is observed appears
to be signiﬁcantly broader for PISA syntheses conducted in the
presence of MTC.39 Both observations are most likely related
to the higher copolymer dispersities that arise from side
reactions (e.g., vinyl addition71) that are known to occur when
Figure 1. Synthesis of PGMA56-P(HPMAy-stat-MTCz) diblock copolymer nano-objects via RAFT statistical copolymerization of HPMA with MTC
in aqueous solution at 70 °C. As the overall target DP (y + z) of the P(HPMA-stat-MTC) core-forming block is increased, polymerization-induced
self-assembly (PISA) occurs to produce either spherical, worm-like, or vesicular nano-objects with cleavable disulﬁde bonds being located within the
hydrophobic P(HPMA-stat-MTC) chains.
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cyclic allylic sulﬁdes are statistically copolymerized with
methacrylic monomers via RAFT.80 Nonetheless, in addition
to the expected dependence on the degree of polymerization
(DP) of the PHPMA block and the concentration at which the
HPMA polymerization is conducted, it is clear that the
copolymer morphology is also sensitive to the proportion of
the more hydrophobic MTC comonomer.39 After conducting
some scouting experiments, we targeted P(HPMA170-stat-
MTC0.85), which formed a predominantly worm-like morphol-
ogy. In principle, cleaving the disulﬁde bonds located in the
methacrylic backbone should signiﬁcantly reduce the core-
forming block DP and hence drive a worm-to-sphere transition.
Comonomer conversions typically reached more than 99%
within approximately 3 h at 70 °C. However, the copoly-
merization was allowed to proceed for a further 13 h to ensure
the highest possible conversion, since this did not appear to be
detrimental to the overall level of control (see Figure S5). The
relative copolymerization rates for HPMA and MTC indicated
that the latter comonomer initially reacted slightly faster than
HPMA but overall was incorporated more or less statistically
into the core-forming block (see 1H NMR spectra in Figure 2).
Addition of tris(2-carboxyethyl)phosphine (TCEP; TCEP/
MTC molar ratio = 5.0) to a stirred 10% w/w aqueous
dispersion of PGMA56-P(HPMA170-stat-MTC0.85) for 16 h at
pH 8−9 led to a marked reduction in Mn from 40000 to 27900
Figure 2. (a, b) 1H NMR spectra obtained for a PGMA56-P(HPMA170-
stat-MTC0.85) copolymer synthesis sampled at various time periods
during RAFT statistical copolymerization of HPMA with MTC at 70
°C and 10% w/w solids in aqueous solution, indicating the signals
utilized to produce the graph shown in (c). (c) Rate of consumption
(as judged by 1H NMR) of HPMA (black squares) and MTC (red
circles) for a PGMA56-P(HPMA170-stat-MTC0.85) copolymer sampled
at various time periods during RAFT polymerization at 70 °C and 10%
w/w in water.
Figure 3. (a) DMF GPC curves recorded for PGMA56-P(HPMA170-
stat-MTC0.85) [denoted as G56-(H170-M0.85) for brevity] copolymers
prepared via RAFT copolymerization of MTC with HPMA using a
PGMA56 macro-CTA at 70 °C before (black curve) and after (red
curve) exposure to TCEP (TCEP/MTC molar ratio = 5.0) at pH 8−9
for 8 days at 20 °C. (b) Evolution of intensity-average particle size
distributions (determined for 0.20% w/w aqueous copolymer
dispersions) before and after a 10% w/w aqueous dispersion of
PGMA56-P(HPMA170-stat-MTC0.85) was exposed to TCEP (TCEP/
MTC molar ratio = 5.0) at pH 8−9 for 1, 5, or 8 days at 20 °C. The
corresponding DLS polydispersities (PDI) are indicated in brackets.
(c) DLS data plotted vs time (days after TCEP addition),
demonstrating the observed reduction in the intensity-average
diameter and count rate.
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g mol−1 with a concomitant increase in Mw/Mn from 1.36 to
1.51, see Figure 3a. This reduction in copolymer Mn is
consistent with the relatively low level of MTC that is
(approximately) statistically incorporated into the hydrophobic
core-forming block. In contrast, no molecular weight reduction
was observed in a control experiment whereby a PGMA56-
PHPMA180 copolymer prepared in the absence of any MTC
was treated with TCEP under the same conditions (see Figure
S6).
This reduction in molecular weight was also suﬃcient to
produce an irreversible worm-to-sphere transition (see DLS
and TEM data shown in Figures 3b,c and 4, respectively). The
ﬁnal morphology is in good agreement with the relatively small
spherical particles obtained for a PGMA56-PHPMA85 copoly-
mer prepared in the absence of MTC (see Figure S7, DLS
diameter = 26 nm and PDI = 0.10). This reference copolymer
was selected because its core-forming block DP is approx-
imately half that of the original PGMA56-P(HPMA170-stat-
MTC0.85). Interestingly, the worm-to-sphere transformation is
relatively slow at 20 °C, requiring 5−8 days at pH 8−9 for the
initial “sphere-equivalent” particle diameter of 136 nm for the
worms to be reduced to a ﬁnal pseudo-spherical particle
diameter of 35 nm. Signiﬁcant reductions in count rate (from
74300 to 27300 kcps) and DLS polydispersity (from 0.30 to
0.14) were also observed for this morphological transition, as
expected (see Figure S3c). It is not yet clear why the
experimental time scales for disulﬁde bond cleavage and the
corresponding change in morphology are so diﬀerent, but it is
perhaps worth emphasizing that this phenomenon proved to be
reproducible. Relatively fast reductive cleavage of the disulﬁde
bonds was anticipated: PHPMA chains are known to be highly
plasticized with water in similar PGMA−PHPMA worms,
which should enable rapid ingress of the TCEP reagent.40
However, the change in copolymer morphology from worms to
(mainly) spheres as a result of the reduction in the packing
parameter is remarkably slow. This may indicate some degree
of recombination of free thiols to form disulﬁdes within the
worms. Alternatively, the relatively high dispersity of the
copolymer chains may play a role: the statistical distribution of
the MTC residues along the core-forming block (see
copolymerization kinetic data in Figure 2) means that there
is minimal change in the packing parameter for a signiﬁcant
fraction of the copolymer chains.84 In fact, assuming a Poisson
distribution it is estimated that up to 43% of the copolymer
chains may not contain any MTC comonomer. Nevertheless,
TEM studies in Figure 4 conﬁrm the DLS data shown in Figure
3: the original worms are indeed eventually converted into
spheres (plus some dimers and trimers) on addition of excess
TCEP at pH 8−9.
■ CONCLUSIONS
MTC has been statistically copolymerized with HPMA using an
aqueous PISA formulation to aﬀord a series of chemically
degradable diblock copolymer nano-objects. RAFT control was
gradually lost and the overall comonomer conversion was
reduced when using higher levels of MTC comonomer and
only a relatively low level of MTC (<1 mol %) could be
tolerated if relatively well-deﬁned spherical, worm-like or
vesicular phases were required. Despite these synthetic
limitations, using MTC as a comonomer enabled disulﬁde
bonds to be incorporated into the methacrylic backbone of the
hydrophobic core-forming block. In the case of the worm
Figure 4. TEM images obtained for a 0.20% w/w aqueous dispersion of PGMA56-P(HPMA170- stat-MTC0.85) before and after exposure to TCEP
(TCEP/MTC molar ratio = 5.0) at pH 8−9 for 8 days at 20 °C. Cartoon representation of the worm-to-sphere transition observed for a 10% w/w
aqueous dispersion of PGMA56-P(HPMA170-stat-MTC0.85) worms on exposure to excess TCEP (TCEP/MTC molar ratio = 5.0) at pH 8−9 for 8
days at 20 °C and the corresponding reduction in the packing parameter.
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morphology, subsequent cleavage of these disulﬁde bonds using
excess TCEP resulted in a suﬃcient reduction in Mn to induce
an irreversible worm-to-sphere transition, which was conﬁrmed
using TEM and DLS. In principle, this chemical degradation
pathway could produce spherical nanoparticles that are
suﬃciently small to allow renal clearance from the body,
boding well for the use of these diblock copolymer nano-
objects in biomedical applications.
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